title: First case of T-cell/histiocyte-rich-large B-cell lymphoma presenting with duodenal obstruction.
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey; arkoksal@gmail.com.
authors.forename: Ali Riza
authors.initials: AR
authors.lastname: Köksal
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Huseyin
authors.initials: H
authors.lastname: Alkim
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Meltem
authors.initials: M
authors.lastname: Ergun
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Salih
authors.initials: S
authors.lastname: Boga
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Bayram
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Canan
authors.initials: C
authors.lastname: Alkim
authors.affiliation: Department of Gastroenterology Sisli Etfal Education and Research Hospital Istanbul, Turkey.
authors.forename: Ozlem Ton
authors.initials: OT
authors.lastname: Eryilmaz
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D004380:Duodenal Obstruction / Q000150:complications / Q000209:etiology*; D005773:Gastroscopy; D006644:Histiocytes / Q000473:pathology*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009325:Nausea / Q000209:etiology; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D013601:T-Lymphocytes / Q000473:pathology*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage; D014839:Vomiting / Q000209:etiology; D015431:Weight Loss
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone